{"id":96,"date":"2015-10-20T23:50:38","date_gmt":"2015-10-20T23:50:38","guid":{"rendered":"http:\/\/kreklewetz.com\/gbmaware\/?p=96"},"modified":"2020-11-18T15:30:39","modified_gmt":"2020-11-18T15:30:39","slug":"fda-expands-optunes-glioblastoma-multiforme-indication","status":"publish","type":"post","link":"https:\/\/www.kreklewetz.com\/gbmaware\/2015\/10\/20\/fda-expands-optunes-glioblastoma-multiforme-indication\/","title":{"rendered":"FDA Expands Optune&#8217;s Glioblastoma Multiforme Indication"},"content":{"rendered":"<p>The FDA recently approved drug, Optune, in combination with temozolomide for patients with newly diagnosed GBMs. This treatment has increased survival rate by 3 months, compared to conventional treatment. Read the <a href=\"http:\/\/www.onclive.com\/web-exclusives\/fda-expands-novottfs-gbm-indication\" target=\"_blank\" rel=\"noopener noreferrer\">full article<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA recently approved drug, Optune, in combination with temozolomide for patients with newly diagnosed GBMs. This treatment has increased survival rate by 3 months, compared to conventional treatment. Read the full article.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[16],"_links":{"self":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts\/96"}],"collection":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/comments?post=96"}],"version-history":[{"count":2,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts\/96\/revisions"}],"predecessor-version":[{"id":219,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/posts\/96\/revisions\/219"}],"wp:attachment":[{"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/media?parent=96"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/categories?post=96"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kreklewetz.com\/gbmaware\/wp-json\/wp\/v2\/tags?post=96"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}